FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592184098> ?p ?o ?g. }

• W2592184098 abstract "Several clinical trials are currently underway for patients with newly diagnosed and recurrent glioblastoma to reinvigorate tumor immunity using immune-checkpoint blockade. However, the CNS is immunologically unique in its maintenance of an immunosuppressive environment, to protect brain cells from autoimmunity and inflammation. Thus, immunotherapy of brain tumors requires novel regimens to overcome tumor immuno-suppression. Suitable preclinical animal models with exhausted tumor-specific immunity are currently not available. We thus hypothesized that a chronic LCMV (cLCMV) strain that induces T cell exhaustion in mice may be co-opted to model the impaired immunity that characterizes brain tumors. In this model, naive and cLCMV-infected mice failed to reject a challenge with glioma in brain when murine glioma cells express one of LCMV antigens (VA-glioma) that are presented via MHC-I. In contrast, mice preimmunized with the acutely-controlled LCMV (aLCMV) strain did reject VA-glioma. In fact, in vitro co-culture of lymphocytes and glioma cells, and in vivo TIL analyses suggested that VA-glioma failed to induce CD8+ T cell responses in cLCMV-mice, in contrast to the robust CD8+ T cell response in aLCMV-mice. Furthermore, cLCMV-specific CD8 T cells lacked a central memory T cell phenotype (CD44+, CD62L-, CD127-) and expressed significantly high levels of PD-1. Thus, treatment with anti-PD1, but not isotype control antibody, successfully reinvigorated and restored antitumor immunity in cLCMV-mice that received VA-glioma cells. PD-1 blockade led to significantly improved survival. However, this treatment did not show a therapeutic effect in cLCMV-mice that received parental glioma cells that don9t express the viral antigen. These data strongly suggest that PD-1 blockade is effective in brain tumors that induce impaired tumor-specific T cell immunity. In conclusion, this novel mouse model may be useful to screen for novel immune checkpoint inhibitors and combination regimes in the setting of a single dysfunctional CD8 T cell response. Citation Format: Hiroshi Nakashima, Quazim Alayo, Pablo Penaloza, Dan Barouch, Ennio Antonio Chiocca. Establishment of a brain tumor model with dysfunctional tumor immunity in mice as a platform for immunotherapeutic evaluation and PD-1 immunotherapy. [abstract]. In: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2016 Oct 20-23; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2017;5(3 Suppl):Abstract nr A53." @default.
• W2592184098 created "2017-03-16" @default.
• W2592184098 creator A5033917464 @default.
• W2592184098 creator A5053749258 @default.
• W2592184098 creator A5054093764 @default.
• W2592184098 creator A5054247332 @default.
• W2592184098 creator A5084380663 @default.
• W2592184098 date "2017-02-28" @default.
• W2592184098 modified "2023-09-26" @default.
• W2592184098 title "Abstract A53: Establishment of a brain tumor model with dysfunctional tumor immunity in mice as a platform for immunotherapeutic evaluation and PD-1 immunotherapy" @default.
• W2592184098 doi "https://doi.org/10.1158/2326-6074.tumimm16-a53" @default.
• W2592184098 hasPublicationYear "2017" @default.
• W2592184098 type Work @default.
• W2592184098 sameAs 2592184098 @default.
• W2592184098 citedByCount "0" @default.
• W2592184098 crossrefType "proceedings-article" @default.
• W2592184098 hasAuthorship W2592184098A5033917464 @default.
• W2592184098 hasAuthorship W2592184098A5053749258 @default.
• W2592184098 hasAuthorship W2592184098A5054093764 @default.
• W2592184098 hasAuthorship W2592184098A5054247332 @default.
• W2592184098 hasAuthorship W2592184098A5084380663 @default.
• W2592184098 hasConcept C147483822 @default.
• W2592184098 hasConcept C154317977 @default.
• W2592184098 hasConcept C167672396 @default.
• W2592184098 hasConcept C193419808 @default.
• W2592184098 hasConcept C202751555 @default.
• W2592184098 hasConcept C203014093 @default.
• W2592184098 hasConcept C2776090121 @default.
• W2592184098 hasConcept C2777701055 @default.
• W2592184098 hasConcept C2778227246 @default.
• W2592184098 hasConcept C2780851360 @default.
• W2592184098 hasConcept C502942594 @default.
• W2592184098 hasConcept C55493867 @default.
• W2592184098 hasConcept C71924100 @default.
• W2592184098 hasConcept C86803240 @default.
• W2592184098 hasConcept C8891405 @default.
• W2592184098 hasConceptScore W2592184098C147483822 @default.
• W2592184098 hasConceptScore W2592184098C154317977 @default.
• W2592184098 hasConceptScore W2592184098C167672396 @default.
• W2592184098 hasConceptScore W2592184098C193419808 @default.
• W2592184098 hasConceptScore W2592184098C202751555 @default.
• W2592184098 hasConceptScore W2592184098C203014093 @default.
• W2592184098 hasConceptScore W2592184098C2776090121 @default.
• W2592184098 hasConceptScore W2592184098C2777701055 @default.
• W2592184098 hasConceptScore W2592184098C2778227246 @default.
• W2592184098 hasConceptScore W2592184098C2780851360 @default.
• W2592184098 hasConceptScore W2592184098C502942594 @default.
• W2592184098 hasConceptScore W2592184098C55493867 @default.
• W2592184098 hasConceptScore W2592184098C71924100 @default.
• W2592184098 hasConceptScore W2592184098C86803240 @default.
• W2592184098 hasConceptScore W2592184098C8891405 @default.
• W2592184098 hasLocation W25921840981 @default.
• W2592184098 hasOpenAccess W2592184098 @default.
• W2592184098 hasPrimaryLocation W25921840981 @default.
• W2592184098 hasRelatedWork W1982531224 @default.
• W2592184098 hasRelatedWork W2043871309 @default.
• W2592184098 hasRelatedWork W2138547625 @default.
• W2592184098 hasRelatedWork W2403617022 @default.
• W2592184098 hasRelatedWork W2463058748 @default.
• W2592184098 hasRelatedWork W2547110778 @default.
• W2592184098 hasRelatedWork W2592596865 @default.
• W2592184098 hasRelatedWork W2593775584 @default.
• W2592184098 hasRelatedWork W2741190163 @default.
• W2592184098 hasRelatedWork W2741892407 @default.
• W2592184098 hasRelatedWork W2771352624 @default.
• W2592184098 hasRelatedWork W2782321008 @default.
• W2592184098 hasRelatedWork W2783246934 @default.
• W2592184098 hasRelatedWork W2804801527 @default.
• W2592184098 hasRelatedWork W2911881300 @default.
• W2592184098 hasRelatedWork W2955170235 @default.
• W2592184098 hasRelatedWork W3089833496 @default.
• W2592184098 hasRelatedWork W3200850106 @default.
• W2592184098 hasRelatedWork W3204668091 @default.
• W2592184098 hasRelatedWork W575671756 @default.
• W2592184098 isParatext "false" @default.
• W2592184098 isRetracted "false" @default.
• W2592184098 magId "2592184098" @default.
• W2592184098 workType "article" @default.